News & Media
Marie Curie Early Career Researcher in Calorimetry for Proton Therapy.
The UCL HEP group is inviting applications for a Marie Curie Early Career Researcher in Proton Therapy. More information is available on our Proton Therapy Marie Curie ECR page. Closing date: 28/3/16.
Proton beam cancer therapy ‘effective with fewer side effects’
“A cancer treatment at the centre of an NHS controversy in 2014 causes fewer side effects in children than conventional radiotherapy, according to new research.
The study, published in The Lancet Oncology, suggests proton beam therapy is as effective as other treatments.”
Proton beam centres ‘to treat 1,500 patients a year’
“Two new NHS proton beam therapy facilities could offer treatment to 1,500 cancer patients a year when they open in the next few years. ...
“On Wednesday, a ceremony at University College London Hospital (UCLH) — attended by Health Secretary Jeremy Hunt — marked the start of construction at one of the sites, due to open in 2019. The other, at the Christie cancer centre in Manchester, will start taking patients in 2018.”
England's first proton beam cancer therapy centre is developed in London
“The new centre, near Euston in central London, will offer the treatment as well as housing Europe's largest blood disorder treatment unit. ...
“BBC London's correspondent Katharine Carpenter speaks to the family of a four-year-old girl who had to travel to America for treatment.”
Work begins on new centre to revolutionise cancer care
“A young cancer patient was the guest of honour at an event to mark the start of work on 25,000 square metres of state of the art cancer and surgical care facilities at UCLH.
“Keeva Hanbury, 4, was joined by Health Secretary Jeremy Hunt and actor and blood cancer campaigner Julian Rhind-Tutt as they officially ‘broke the ground’ at the site of UCLH’s new integrated proton beam therapy (PBT) and specialist cancer and surgical treatment facility.”
“... Improving ion beam therapy for enhanced cancer treatment is the goal of a new European research and training network that will focus on the Optimisation of Medical Accelerators (OMA).
The OMA project joins 24 institutions from all across Europe and will be coordinated by the Cockcroft Institute in the UK during its 4 year duration. The consortium has been awarded almost
Interview: With Proton Precision
Simon Jolly talks to David Smith about his early physics career and his current involvement in proton therapy in the UK.
Bouygues starts £190m London cancer hospital
“Bouygues UK has started work on the construction of a new hospital dedicated to specialist cancer treatment in central London. University College London Hospitals (UCLH) NHS Foundation Trust signed the £190m contract with Bouygues UK in July. ...”
Could proton beam therapy help cure the UK's toughest cancers?
“... The UK currently has a low-energy NHS proton beam facility at Clatterbridge cancer centre, in the Wirral, suitable for treating rare cancers of the eye, but complex cases need high energy proton beam therapy. ...”
PR Newswire: Varian Medical Systems Selected to Equip Two National Proton Therapy Centers in England
“... Under a public tender, Varian was selected as the preferred supplier to provide equipment and service to operate two three-room centers to be constructed in London and Manchester in a contract valued at up to £80 million. ...”
UK Gov: Green light for 2 proton beam therapy centres
“The building of 2 proton beam therapy cancer treatment centres at University College London Hospitals NHS Foundation Trust and the Christie NHS Foundation Trust in Manchester will start this summer. Varian Medical Systems has been named as the equipment supplier for both, with Bouygues UK as the building contractor for UCLH and Interserve Construction Ltd at the Christie.
“The government has invested £250 million in the facilities to give NHS patients a highly-targeted type of radiotherapy that can treat hard-to-reach cancers without causing damage to surrounding tissue or other side effects. The centres are expected to open for patients in 2018.”
UCLH: Green light for proton beam therapy centre.
“The Department of Health has announced the preferred contractors for the building and supply of equipment for the proton beam therapy (PBT) service which will treat hundreds of patients each year at University College Hospital from 2018.
“UCLH’s preferred building contractor is Bouyges UK and the preferred equipment supplier for both the Christie and UCLH is Varian. Both were selected following a rigorous public procurement process.”
UCLH a step closer to UK's most advanced cancer treatment.
“ ...The Rosenheim Wing on Grafton Way, together with the adjacent vacant site, known as the Odeon site, will make way for a new patient facility which, subject to final approval, will include a PBT centre.
“David Probert, UCLH’s strategic development director, is overseeing the development programme with Kieran McDaid, UCLH’s director of estates leading on the construction project. David said, “The Rosenheim Wing is being taken down ‘brick by brick’ to minimise the disruption to the people and buildings in the area." ...
“It’s the end of an era for the Rosenheim Wing which was home to several clinical services until earlier this year when it closed to make way for the new facility.
“The building was named after Max Rosenheim. Max was originally appointed as a research assistant in the obstetric unit at University College Hospital in 1934 and rose through the ranks to become deputy director of the metabolic unit. He was knighted in 1967 and the building was renamed the Rosenheim Wing after his death in the early 1970s. The Rosenheim Wing is also remembered as the place where George Orwell died in 1950.
“The adjacent site has been vacant since the Odeon cinema was demolished in 1960.”
Reuters: Cancer-zapping proton therapy only suitable for rare patients.
“ ... Simon Jolly, a lecturer in accelerator physics at University College London (UCL), said these key features of the proton beam make it highly suited to some hard-to-reach tumors, or tumors growing very close to other key organs that could be badly affected by radiation, such as the brain stem or spinal cord. ‘What you're trying to do is deliver dose to the cells that you want to kill... and do it in a targeted way,’ Jolly told reporters at a briefing for reporters given by experts on proton therapy. ‘The key advantage with the proton is that it goes in and then stops. And it dumps must of its energy, doing most of its damage, at the end of its path. So not only are you doing less damage on the way in, but it also means that if there are sensitive areas on the far side of the tumor, you will not damage them.’ ... ”